IDEXX Laboratories, Inc. (1IDXX)
MTA
476.20
-13.10 (-2.68%)
Closed
Aug 24, 2026
Day's Range
476.20489.40
52 wk Range
466.10664.60
Financial Statements - 1IDXX - IDEXX Laboratories, Inc.
Revenue
4.30B▲ 30.3%
Net Income
1.05B▲ 40.9%Net Margin 24.6%
EBITDA
1.50B▲ 40.1%
Free Cash Flow
1.04B▲ 54.3%
Income Statement
| Period Ending | 2025-12-31 | 2024-12-31 |
|---|---|---|
| Sales | 4.30B | 3.30B |
| Cost of Goods | 1.64B | 1.28B |
| Gross Profit | 2.65B | 2.01B |
 Operating Expense | - | - |
| Operating Income | 1.36B | 955.90M |
| Non-Operating Interest | - | - |
| Other Income Expense | - | - |
| Pre Tax Income | 1.32B | 940.22M |
| Income Tax | 264.72M | 188.04M |
| Net Income | 1.05B | 752.18M |
| EPS Basic | 13.17 | 10.77 |
| EPS Diluted | 13.08 | 10.67 |
| Basic Shares Outstanding | 80.42M | 69.86M |
| Diluted Shares Outstanding | 80.42M | 69.86M |
| Ebit | 1.36B | 966.66M |
| Ebitda | 1.50B | 1.07B |
| Net Income Continuous Operations | 1.05B | 752.18M |
| Minority Interests | - | - |
| Preferred Stock Dividends | - | - |
The information on this page is provided for general informational purposes only and is not investment advice.
Market data provided by Twelve Data. Charting by TradingView.
Last updated:
